Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
49
IMRN Quote, Financials, Valuation and Earnings
Last price:
$1.78
Seasonality move
:
14.68%
Day range:
$1.94 - $1.94
52-week range:
$1.59 - $5.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.44x
P/B ratio:
1.30x
Volume:
215
Avg. volume:
5.4K
1-year change:
-0.51%
Market cap:
$11M
Revenue:
$3.2M
EPS (TTM):
-$0.80
Analysts' Opinion
-
Consensus RatingImmuron has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Immuron has an estimated upside of 157.76% from its current price of $1.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.94.
Fair Value
-
According to the consensus of 0 analysts, Immuron has 157.76% upside to fair value with a price target of -- per share.
IMRN vs. S&P 500
-
Over the past 5 trading days, Immuron has underperformed the S&P 500 by -12.35% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Immuron does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Immuron has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Immuron reported revenues of --.
Earnings Growth
-
Immuron has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Immuron reported earnings per share of --.
Enterprise value:
3.3M
EV / Invested capital:
--
Price / LTM sales:
3.44x
EV / EBIT:
--
EV / Revenue:
1.01x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.2M
Return On Assets:
-35.51%
Net Income Margin (TTM):
-141.8%
Return On Equity:
-40.9%
Return On Invested Capital:
-40.9%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3M | $19.3M | $16.3M | $13.5M | $9.8M | |
| Total Assets | $4.3M | $20.3M | $17.1M | $14.6M | $10.4M | |
| Current Liabilities | $354.8K | $842.9K | $1M | $1.5M | $1.8M | |
| Total Liabilities | $383.6K | $870.1K | $1.2M | $1.6M | $1.9M | |
| Total Equity | $3.9M | $19.5M | $15.9M | $13M | $8.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
IMRN
Sector
Market Cap
$11M
$46.1M
Price % of 52-Week High
32.55%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-0.51%
-30.52%
Beta (5-Year)
1.352
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.03
200-day SMA
Sell
Level
$2.37
Bollinger Bands (100)
Sell
Level
1.93 - 2.61
Chaikin Money Flow
Sell
Level
-118.2M
20-day SMA
Sell
Level
$2.02
Relative Strength Index (RSI14)
Sell
Level
44.79
ADX Line
Sell
Level
25.65
Williams %R
Buy
Level
-85.4545
50-day SMA
Sell
Level
$1.96
MACD (12, 26)
Buy
Level
0.00
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
349.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.9554)
Sell
CA Score
(Annual)
Level (-0.3488)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (4.5387)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Stock Forecast FAQ
In the current month, IMRN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IMRN average analyst price target in the past 3 months is --.
-
Where Will Immuron Stock Be In 1 Year?
According to analysts, the consensus estimate is that Immuron share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Immuron?
Analysts are divided on their view about Immuron share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Immuron is a Sell and believe this share price will drop from its current level to --.
-
What Is Immuron's Price Target?
The price target for Immuron over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IMRN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Immuron is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IMRN?
You can purchase shares of Immuron via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Immuron shares.
-
What Is The Immuron Share Price Today?
Immuron was last trading at $1.78 per share. This represents the most recent stock quote for Immuron. Yesterday, Immuron closed at $1.94 per share.
-
How To Buy Immuron Stock Online?
In order to purchase Immuron stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
